Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Stevia Nutra Corp STNT

Consumer Defensive Farm Products
Stevia Nutra Corp is engaged in the business of cultivation, development, and post-harvest processing of Stevia plants for use as a sweetener. It provides raw stevia to wholesalers and manufacturers who create a wide range of products for consumption. It is also into producing Hemp.

Recent & Breaking News (GREY:STNT)

STENTYS Reports 2016 First-Half Results

Business Wire September 15, 2016

STENTYS : Mise à disposition du document de référence 2015

Business Wire August 30, 2016

STENTYS : Bilan semestriel du contrat de liquidité conclu avec la société de bourse GILBERT DUPONT

Business Wire July 26, 2016

STENTYS recrute le premier patient de son étude clinique sur l’artère principale du cœur

Business Wire July 19, 2016

STENTYS Enrolls First Patient in Left Main Clinical Trial

Business Wire July 19, 2016

QUANTEL : MISE À DISPOSITION DU DOCUMENT DE RÉFÉRENCE 2015

Business Wire July 12, 2016

STENTYS : croissance de 41% du chiffre d’affaires au 2ème trimestre 2016

Business Wire July 12, 2016

OSE Immunotherapeutics presents new preclinical efficacy results with Effi-DEM, a new generation checkpoint inhibitor, at the “European Association for Cancer Research” (EACR) Congress (Manchester, 9-12 July 2016)

Business Wire July 12, 2016

Safe Orthopaedics : Chiffre d’affaires ajusté du 2ème trimestre 2016 : +29%

Business Wire July 12, 2016

MEDIAN Technologies Strengthens Its Medical Expertise Department by Appointing Dr. Nathalie Faye as Medical Director Europe

Business Wire July 12, 2016

OSE Immunotherapeutics présente des nouveaux résultats précliniques d’efficacité avec Effi-DEM, checkpoint inhibiteur de nouvelle génération, au congrès de l’Association Européenne de Recherche sur le Cancer

Business Wire July 12, 2016

MEDIAN Technologies renforce sa direction médicale avec la nomination du Dr. Nathalie Faye au poste de Directrice Médicale Europe

Business Wire July 12, 2016

STENTYS: 41% Increase in Revenues in the Second Quarter of 2016

Business Wire July 12, 2016

STENTYS : nomination d’un nouveau Directeur Général spécialiste du Medtech cardiologique

Business Wire July 4, 2016

STENTYS: Appointment of Cardiolovascular Device Veteran as New CEO

Business Wire July 4, 2016

Teleperformance: Half-Year Liquidity Contract Statement

Business Wire July 4, 2016

Teleperformance : Bilan semestriel du contrat de liquidité

Business Wire July 4, 2016

Axway: Information of the Total Number of Voting Rights and Shares of Axway Software Share Capital as at May 31, 2016

Business Wire June 8, 2016

STENTYS annonce le marquage CE du plus long stent Xposition

Business Wire June 8, 2016

STENTYS Announces CE Marking of Its Longest Xposition Stent

Business Wire June 8, 2016